(Q54070862)

24 May 2018

title

Comparison of vasodilator potency of adrenomedulling and proadrenomedullin N-terminal 20 peptide in human. (English)

1 reference

24 May 2018

author name string

Nakamura M

series ordinal

1

1 reference

24 May 2018

Yoshida H

series ordinal

2

1 reference

24 May 2018

Hiramori K

series ordinal

3

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

24 May 2018

published in

Life Sciences

1 reference

24 May 2018

volume

65

1 reference

24 May 2018

issue

20

1 reference

24 May 2018

page(s)

2151-2156

1 reference

24 May 2018

Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Proadrenomedullin NH2-terminal peptide (PAMP)(12-20) has vasodepressor activity in the rat and cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Proadrenomedullin-derived peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Elevation of circulating proadrenomedullin-N terminal 20-peptide in thyrotoxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Plasma proadrenomedullin N-terminal 20 peptide (PAMP) in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Tone-dependent vasodilator responses to proadrenomedullin NH2-terminal 20 peptide in the hindquarters vascular bed of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

A newly identified peptide, proadrenomedullin N-terminal 20 peptide, induces hypotensive action via pertussis toxin-sensitive mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900480-4

10.1016/S0024-3205(99)00480-4

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018